Search

Search Constraints

You searched for: Author/Creator Fassina, Giorgio

Search Results

1. Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma. Issue 2 (3rd December 2014)

2. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients. (3rd April 2018)

3. Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients. (18th August 2017)

4. Clinical evaluation of the iXip index to reduce prostate re-biopsies. (2018)

5. Clinical validation of the iXip index in avoiding unnecessary prostate biopsy: Results from a prospective multicenter study involving 426 patients. (2017)

6. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients. Issue 2 (May 2018)

7. Specificity of squamous cell carcinoma antigen (SCCA)‐IgM detection in patients with HCV infection and rheumatoid factor seropositivity. Issue 6 (12th April 2013)

8. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. Issue 2 (February 2016)